{"id":"https://openalex.org/W2004018032","doi":"https://doi.org/10.1097/hjh.0b013e3282f52c36","title":"Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-\u03b3-modulating activity, on nitric oxide bioavailability and atherosclerotic change","display_name":"Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-\u03b3-modulating activity, on nitric oxide bioavailability and atherosclerotic change","alternate_titles":[],"publication_year":2008,"publication_date":"2008-04-01","ids":{"openalex":"https://openalex.org/W2004018032","doi":"https://doi.org/10.1097/hjh.0b013e3282f52c36","mag":"2004018032","pmid":"https://pubmed.ncbi.nlm.nih.gov/18398339"},"language":"en","primary_location":{"id":"doi:10.1097/hjh.0b013e3282f52c36","doi":"https://doi.org/10.1097/hjh.0b013e3282f52c36","is_oa":false,"landing_page_url":"https://doi.org/10.1097/hjh.0b013e3282f52c36","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2004018032"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088861691","display_name":"Hideyuki Ikejima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hideyuki Ikejima","raw_affiliation_strings":["Department of Cardiovascular Medicine, Wakayama Medical University Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Wakayama Medical University Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059425294","display_name":"Toshio Imanishi","orcid":"https://orcid.org/0000-0003-3355-9196","observed_orcids":["https://orcid.org/0000-0003-3355-9196"]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Toshio Imanishi","raw_affiliation_strings":["Department of Cardiovascular Medicine, Wakayama Medical University Japan","to Toshio Imanishi MD, PhD, Department of Cardiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama City, Wakayama 641-8510, Japan Tel: +81 73 441 0621; fax: +81 73 446 0631; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: +81 73 446 0631","to Toshio Imanishi MD, PhD, Department of Cardiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama City, Wakayama 641-8510, Japan Tel: +81 73 441 0621"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Wakayama Medical University Japan","institution_ids":["https://openalex.org/I190805021"]},{"raw_affiliation_string":"to Toshio Imanishi MD, PhD, Department of Cardiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama City, Wakayama 641-8510, Japan Tel: +81 73 441 0621; fax: +81 73 446 0631; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I190805021"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +81 73 446 0631","institution_ids":[]},{"raw_affiliation_string":"to Toshio Imanishi MD, PhD, Department of Cardiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama City, Wakayama 641-8510, Japan Tel: +81 73 441 0621","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045305420","display_name":"Hiroto Tsujioka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroto Tsujioka","raw_affiliation_strings":["Department of Cardiovascular Medicine, Wakayama Medical University Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Wakayama Medical University Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059019226","display_name":"Akio Kuroi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akio Kuroi","raw_affiliation_strings":["Department of Cardiovascular Medicine, Wakayama Medical University Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Wakayama Medical University Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025333302","display_name":"Katsunobu Kobayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katsunobu Kobayashi","raw_affiliation_strings":["Department of Cardiovascular Medicine, Wakayama Medical University Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Wakayama Medical University Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075639265","display_name":"Masashi Shiomi","orcid":"https://orcid.org/0000-0003-4742-4022","observed_orcids":["https://orcid.org/0000-0003-4742-4022"]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masashi Shiomi","raw_affiliation_strings":["Institute for Experimental Animals, Kobe University School of Medicine, Kobe Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Experimental Animals, Kobe University School of Medicine, Kobe Japan","institution_ids":["https://openalex.org/I65837984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018979358","display_name":"Yasuteru Muragaki","orcid":"https://orcid.org/0000-0002-6506-9178","observed_orcids":["https://orcid.org/0000-0002-6506-9178"]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuteru Muragaki","raw_affiliation_strings":["Department of Pathology, Wakayama Medical University, Wakayama Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Wakayama Medical University, Wakayama Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109419091","display_name":"Seiichi Mochizuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189996419","display_name":"Kawasaki Medical School","ror":"https://ror.org/059z11218","country_code":"JP","type":"education","lineage":["https://openalex.org/I189996419"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Seiichi Mochizuki","raw_affiliation_strings":["Department of Medical Engineering, Kawasaki Medical School Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Engineering, Kawasaki Medical School Japan","institution_ids":["https://openalex.org/I189996419"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110025375","display_name":"Masami Goto","orcid":"https://orcid.org/0000-0002-1436-2040","observed_orcids":["https://orcid.org/0000-0002-1436-2040"]},"institutions":[{"id":"https://openalex.org/I189996419","display_name":"Kawasaki Medical School","ror":"https://ror.org/059z11218","country_code":"JP","type":"education","lineage":["https://openalex.org/I189996419"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masami Goto","raw_affiliation_strings":["Department of Medical Engineering, Kawasaki Medical School Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Engineering, Kawasaki Medical School Japan","institution_ids":["https://openalex.org/I189996419"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077761521","display_name":"Kiyoshi Yoshida","orcid":"https://orcid.org/0000-0002-3040-102X","observed_orcids":["https://orcid.org/0000-0002-3040-102X"]},"institutions":[{"id":"https://openalex.org/I189996419","display_name":"Kawasaki Medical School","ror":"https://ror.org/059z11218","country_code":"JP","type":"education","lineage":["https://openalex.org/I189996419"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kiyoshi Yoshida","raw_affiliation_strings":["Division of Cardiology, Kawasaki Medical School, Okayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiology, Kawasaki Medical School, Okayama, Japan","institution_ids":["https://openalex.org/I189996419"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000322274","display_name":"Takashi Akasaka","orcid":"https://orcid.org/0000-0003-3020-9369","observed_orcids":["https://orcid.org/0000-0003-3020-9369"]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takashi Akasaka","raw_affiliation_strings":["Department of Cardiovascular Medicine, Wakayama Medical University Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Wakayama Medical University Japan","institution_ids":["https://openalex.org/I190805021"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5059425294"],"corresponding_institution_ids":["https://openalex.org/I190805021"],"apc_list":null,"apc_paid":null,"fwci":3.782,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.92752082,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"26","issue":"5","first_page":"964","last_page":"972"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.5073000192642212,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.5073000192642212,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.34790000319480896,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0568000003695488,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telmisartan","display_name":"telmisartan","score":1.0},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.8970000147819519},{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.7789999842643738},{"id":"https://openalex.org/keywords/nitric-oxide-bioavailability","display_name":"nitric oxide bioavailability","score":0.8970000147819519},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.9070000052452087},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9319999814033508},{"id":"https://openalex.org/keywords/3-nitrotyrosine","display_name":"nitrotyrosine","score":0.875},{"id":"https://openalex.org/keywords/endothelial-nitric-oxide-synthase","display_name":"endothelial nitric oxide synthase","score":0.9649999737739563},{"id":"https://openalex.org/keywords/gw9662","display_name":"GW9662","score":0.8500000238418579},{"id":"https://openalex.org/keywords/candesartan","display_name":"candesartan","score":0.9890000224113464},{"id":"https://openalex.org/keywords/aortic-plaque","display_name":"aortic plaque","score":0.7609999775886536},{"id":"https://openalex.org/keywords/ppargamma-antagonist","display_name":"PPAR\u03b3 antagonist","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C2779716603","wikidata":"https://www.wikidata.org/wiki/Q733186","display_name":"Telmisartan","level":3,"score":0.9774668216705322},{"id":"https://openalex.org/C2780036600","wikidata":"https://www.wikidata.org/wiki/Q415970","display_name":"Candesartan","level":4,"score":0.9403190016746521},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.6723009943962097},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6386017799377441},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5358895659446716},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5297901034355164},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.5173944234848022},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4851135015487671},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.4644940197467804},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.4223068654537201},{"id":"https://openalex.org/C2777622882","wikidata":"https://www.wikidata.org/wiki/Q417619","display_name":"Nitric oxide synthase","level":3,"score":0.41506901383399963},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.32990849018096924},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.04255971312522888}],"mesh":[{"descriptor_ui":"D000077333","descriptor_name":"Telmisartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000813","descriptor_name":"Anilides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001012","descriptor_name":"Aorta, Abdominal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001012","descriptor_name":"Aorta, Abdominal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001012","descriptor_name":"Aorta, Abdominal","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009569","descriptor_name":"Nitric Oxide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/hjh.0b013e3282f52c36","doi":"https://doi.org/10.1097/hjh.0b013e3282f52c36","is_oa":false,"landing_page_url":"https://doi.org/10.1097/hjh.0b013e3282f52c36","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:18398339","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18398339","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1576835394","https://openalex.org/W1974906595","https://openalex.org/W1978245407","https://openalex.org/W1981018813","https://openalex.org/W1982581996","https://openalex.org/W1988531324","https://openalex.org/W1993952575","https://openalex.org/W1999649376","https://openalex.org/W2008047670","https://openalex.org/W2008048680","https://openalex.org/W2019249650","https://openalex.org/W2025553759","https://openalex.org/W2042038416","https://openalex.org/W2048748448","https://openalex.org/W2050548878","https://openalex.org/W2065133286","https://openalex.org/W2072477280","https://openalex.org/W2080138126","https://openalex.org/W2089592415","https://openalex.org/W2117854326","https://openalex.org/W2124166947","https://openalex.org/W2129380039","https://openalex.org/W2129697991","https://openalex.org/W2159083249","https://openalex.org/W2159316372","https://openalex.org/W2159424655"],"related_works":["https://openalex.org/W2096617951","https://openalex.org/W1998196471","https://openalex.org/W2979839209","https://openalex.org/W2143438941","https://openalex.org/W2079095984","https://openalex.org/W1966277724","https://openalex.org/W2015941089","https://openalex.org/W2021784922","https://openalex.org/W1985866304"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Telmisartan":[1,139],"is":[2],"a":[3,69,106,245],"unique":[4],"angiotensin":[5],"II":[6],"(Ang":[7],"II)":[8],"receptor":[9],"blocker":[10],"(ARB)":[11],"with":[12,37,63,153,166],"selective":[13],"peroxisome":[14],"proliferator-activated":[15],"receptor-gamma":[16],"(PPAR":[17],"gamma).":[18],"We":[19],"therefore":[20],"investigated":[21],"the":[22,163,176,185,197,207,216,221,229,234],"effects":[23,254,266],"of":[24,48,117,215,248],"telmisartan":[25,78,84,186,198,210,230,237,250],"on":[26,255],"endothelial":[27,127],"function":[28],"and":[29,112,119,179,259],"atherosclerotic":[30,260],"change":[31,261],"in":[32,175,184,196,206,228,233,267],"genetically":[33,268],"hyperlipidemic":[34,52,269],"rabbits,":[35],"compared":[36],"candesartan,":[38],"an":[39],"ARB":[40],"without":[41],"PPAR":[42,70,264],"gamma":[43,71],"activity.":[44,131],"METHODS:":[45],"A":[46],"total":[47],"30":[49],"Watanabe":[50],"heritable":[51],"(WHHL)":[53],"rabbits":[54],"equally":[55],"derived":[56],"(n":[57],"=":[58],"6":[59],"each)":[60],"were":[61],"treated":[62],"(1)":[64],"vehicle":[65],"(control),":[66],"(2)":[67],"GW9662,":[68,86],"antagonist":[72],"(0.5":[73],"mg/kg":[74,80,90],"per":[75,81,91],"day),":[76,82],"(3)":[77],"(5":[79,89],"(4)":[83],"+":[85,211,238],"(5)":[87],"candesartan":[88,188,208,235],"day)":[92],"for":[93,108,124],"8":[94],"weeks.":[95],"After":[96],"treatment,":[97],"acetylcholine":[98],"(ACh)-induced":[99],"nitric":[100,120,128,142,159,256],"oxide":[101,129,143,160,257],"production":[102],"was":[103,122,134,171,194,201,224],"measured":[104,123],"as":[105],"surrogate":[107],"endothelium":[109],"protective":[110],"function,":[111],"vascular":[113],"nitrotyrosine":[114,169,192],"(a":[115],"product":[116],"superoxide":[118],"oxide)":[121],"assessing":[125],"dysfunctional":[126],"synthase":[130],"Plaque":[132],"area":[133,223],"quantified":[135],"by":[136,144],"histology.":[137],"RESULTS:":[138],"increased":[140],"ACh-induced":[141,158],"5.5":[145],"nmol/l,":[146],"significantly":[147,155,180,202,226],"more":[148,225],"than":[149,182,204,232],"control.":[150],"Interestingly,":[151],"cotreatment":[152],"GW9662":[154,212,239],"attenuated":[156],"telmisartan-induced":[157],"almost":[161],"to":[162,244],"levels":[164],"observed":[165,195],"candesartan.":[167],"Vascular":[168],"concentration":[170,193],"1.4":[172],"pmol/mg":[173],"protein":[174],"control":[177],"group":[178,231],"higher":[181],"that":[183,205,220],"or":[187,209,236],"group.":[189,213,240],"The":[190],"lowest":[191],"group,":[199],"which":[200],"lower":[203],"Histology":[214],"thoracic":[217],"aorta":[218],"revealed":[219],"plaque":[222],"decreased":[227],"CONCLUSION:":[241],"In":[242],"addition":[243],"class":[246],"effect":[247],"ARBs,":[249],"may":[251],"have":[252],"additional":[253],"bioavailability":[258],"through":[262],"its":[263],"gamma-mediated":[265],"rabbits.":[270]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2004018032","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
